While opioids have the potential to regulate certain pathological processes, these effects fail to translate to therapeutic benefits in AD due to their strong association with cognitive impairment, hyperphosphorylated tau protein and neuroinflammation [271, 272]. Here, MAPT is linked to Alzheimer disease.